
Sequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core/shell nanoparticles sensitizes drug-resistant breast cancer cells
Keywords: EGFR; Epidermal growth factor receptor; HER2; Human epidermal growth factor receptor 2; MES; 2-(N-morpholino)ethanesulfonic acid; PBS; Phosphate buffered saline; EDC; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; Sulfo-NHS; Sulfo-N-hydroxysuccinimide; NF